SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)
Japan1,620 participantsStarted 2021-12-21
Plain-language summary
To collect information on and evaluate the long-term safety and effectiveness of Anifrolumab in patients with systemic lupus erythematosus in the real-world post-marketing setting.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
patients with systemic lupus erythematosus insufficiently responding to currently available treatment -
Exclusion Criteria:
None
\-
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this is a post-marketing surveillance study in Japan tracking adverse drug reactions to SAPHNELO rather than testing a new treatment, could you help me understand how the safety data being collected here might be relevant to my own treatment decisions with this drug?
2This study is no longer enrolling new participants — does that mean the results or safety findings collected so far are available, and if so, what have they shown about how people with systemic lupus erythematosus are tolerating SAPHNELO in real-world use?
3Because this surveillance study is specifically focused on tracking side effects and adverse drug reactions, what are the most important safety signals I should be aware of and watching for if SAPHNELO is something my care team is considering for me?
4How does the safety information being gathered in this kind of real-world surveillance study compare to what was already known from the clinical trials that got SAPHNELO approved, and does it change your thinking about recommending it?
5Before considering SAPHNELO, would you walk me through what standard treatment options are available for my type of lupus, and under what circumstances would a newer drug like this be a better path than those existing options?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.